Icariin attenuates asthmatic airway inflammation via modulating alveolar macrophage activation based on network pharmacology and in vivo experiments
Authors:
- 9 July 2024
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 26 (7) , e3718
Abstract
Background: Icariin (ICA) inhibits inflammatory response in various diseases, but the mechanism underlying ICA treating airway inflammation in asthma needs further understood. We aimed to predict and validate the potential targets of ICA against asthma‐associated airway inflammation using network pharmacology and experiments.Methods: The ovalbumin‐induced asthma‐associated airway inflammation mice model was established. The effects of ICA were evaluated by behavioral, airway hyperresponsiveness, lung pathological changes, inflammatory cell and cytokines counts. Next, the corresponding targets of ICA were mined via the SEA, CTD, HERB, PharmMapper, Symmap database and the literature. Pubmed‐Gene and GeneCards databases were used to screen asthma and airway inflammation‐related targets. The overlapping targets were used to build an interaction network, analyze gene ontology and enrich pathways. Subsequently, flow cytometry, quantitative real‐time PCR and western blotting were employed for validation.Results: ICA alleviated the airway inflammation of asthma; 402 targets of ICA, 5136 targets of asthma and 4531 targets of airway inflammation were screened; 216 overlapping targets were matched and predicted ICA possesses the potential to modulate asthmatic airway inflammation by macrophage activation/polarization. Additionally, ICA decreased M1 but elevated M2. Potential targets that were disrupted by asthma inflammation were restored by ICA treatment.Conclusions: ICA alleviates airway inflammation in asthma by inhibiting the M1 polarization of alveolar macrophages, which is related to metabolic reprogramming. Jun, Jak2, Syk, Tnf, Aldh2, Aldh9a1, Nos1, Nos2 and Nos3 represent potential targets of therapeutic intervention. The present study enhances understanding of the anti‐airway inflammation effects of ICA, especially in asthma.Keywords
Funding Information
- National Natural Science Foundation of China (82174170)
This publication has 99 references indexed in Scilit:
- Dexamethasone and potassium canrenoate alleviate hyperalgesia by competitively regulating IL‐6/JAK2/STAT3 signaling pathway during inflammatory pain in vivo and in vitroImmunity, Inflammation and Disease, 2022
- α‐Asarone alleviates allergic asthma by stabilizing mast cells through inhibition of ERK/JAK2‐STAT3 pathwayBioFactors, 2022
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Interleukins 6/8 and cyclooxygenase‐2 release and expressions are regulated by oxidative stress‐JAK2/STAT3 signaling pathway in human bronchial epithelial cells exposed to particulate matter ≤2.5 μmJournal of Applied Toxicology, 2020
- Anti‐colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental dataJournal of Cellular Biochemistry, 2019
- Orthopaedic implant materials drive M1 macrophage polarization in a spleen tyrosine kinase- and mitogen-activated protein kinase-dependent mannerActa Biomaterialia, 2018
- Effects of Acetaldehyde on Human Airway Constriction and Inflammation2006
- Mediators of Asthma: Nitric oxidePulmonary Pharmacology & Therapeutics, 2002
- A Neuronal NO Synthase (NOS1) Gene Polymorphism Is Associated with AsthmaBiochemical and Biophysical Research Communications, 2000
- Blockade of JAK2 by Tyrphostin AG-490 Inhibits Antigen-Induced Eosinophil Recruitment into the Mouse AirwaysBiochemical and Biophysical Research Communications, 2000